Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: A long-term follow-up analysis

European Journal of Haematology

Volumn 64, Issue 1, 2000, Pages 47-52

  Damasio, E E ^a   Clavio, M ^b   Masoudi, B ^b   Isaza, A ^b   Spriano, M ^b   Rossi, E ^b   Casciaro, S ^b   Cerri, R ^b   Risso, M ^b   Nati, S ^b   Siccardi, M ^b   Truini, M ^a   Gobbi, M ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE

Author keywords

Alpha interferon; HCL

Indexed keywords

ALPHA INTERFERON; PURINE DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; DISEASE CONTROL; FEMALE; FOLLOW UP; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE MARROW; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-ALPHA; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SPLENECTOMY; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033964436     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90014.x     Document Type: Article

References (31)

1. 1. Bouroncle BA, Wiseman BK, Doan LA. Leukemic reticulo-endotheliosis. Blood 1958;13:609-630.
2. 2. Damasio EE, Masoudi B. Hairy cell leukemia: update. Forum 1996;6:295-305.
3. 3. Jansen J, Hermans J. Splenectomy in hairy cell leukemia: a retrospective multicenter analysis. Cancer 1981;47:2066-2076.
4. 4. Quesada JR, Reuben J, Mamming JT, et al. Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 1984;310:15-18.
5. 5. Lauria F, Foa R, Raspadori D, et al. Treatment of hairy cell leukemia with alpha interferon. Eur J Canc Clin Oncol 1988;24:195-200.
6. 6. Federico M, Chisesi T, Lauria F, et al. Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicentre study in non-splenectomized patients. Br J Haematol 1988;72:54-56.
7. 7. Berman E, Heeler G, Kempin S, Gee T, Tran LL, Clarkson B. Incidence of response and long term follow up in patients with hairy cell leukemia treated with recombinant interferon. Blood 1990;75:839-842.
8. 8. Capnist G, Federico M, Chisesi T, et al. (for the Italian Cooperative Group of Hairy Cell Leukemia). Long term results of interferon treatment in hairy cell leukemia. Leuk Lymphoma 1994;14:457-464.
9. 9. Rai KR, Davey F, Peterson B, et al. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long term follow up results of study by Cancer and Leukemia group B. Leukemia 1995;9:1116-1120.
10. 10. Spiers ASD, Moore D, Cassileth PA, et al. Remission in hairy cell leukemia with pentostatin (2′-deoxycoformycin). N Engl J Med 1987;316:825-830.
11. 11. Piro LD, Carrera CJ, Carsont DA, et al. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;332: 1117-1121.
12. 12. Kraut EH, Grever M, Bouroncle BA. Long-term follow up of patients with hairy cell leukemia after treatment with 2′-deoxycoformycin. Blood 1994;12:4061-4063.
13. 13. Saven A, Piro L. Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med 1994;330:691-697.
14. 14. Tallman MS, Hakimian D, Rademaker AW, et al. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long term follow up of the Northwestern University experience. Blood 1996;88:1954-1959.
15. 15. Hoffman MA, Janson D, Rose E, Rai K. Treatment of hairy-cell leukemia with cladribine: response, toxicity and long term follow up. J Clin Oncol 1997;15:1138-1142.
16. 16. Lauria F, Rondelli D, Zinzani PL, et al. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-yr survey. Leukemia 1997;11: 629-632.
17. 17. Cheson BD, Sorensen MD, Vena DA, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (Cladribine) via the Group C Protocol Mechanism of the National Cancer Institute: a report of 979 patients. J Clin Oncol 1998; 16:3007-3015.
18. 18. Hounieu H, Chittal SM, Saati AL, et al. Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin-embedded sections by monoclonal antibody DBA44. Am J Clin Pathol 1992;98:26-33.
19. 19. Andriani A, Bibas M, Callea V, et al. Autoimmune haemolytic anemia during alpha-interferon treatment in nine patients with haematological disease. Haematologica 1996;81:258-260.
20. 20. Seymour JF, Estey EH, Keating MJ, Kurzrock R. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Leukemia 1995;9:929-932.
21. 21. Filleul B, Delannoy A, Ferrant A, et al. A single course of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 1994;8:1153-1156.
22. 22. Carbone A, Reato G, Di Celle P, Lauria F, Foa R. Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia 1994;8:2019-2021.
23. 23. Zaja F, Fanin R, Silvestri F, Russo D, Infanti L, Baccarani M. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine. Haematologica 1997;82:468-470.
24. 24. Frassoldati A, Lamparelli T, Federico M, et al. Hairy cell leukemia: a clinical review based on 725 cases of the Italian cooperative group (ICGHCL). Leuk Lymphoma 1994;13: 307-316.
25. 25. Zinzani PL, Lauria F, Salvucci M, et al. Hairy cell leukemia and alpha-interferon treatment: long term responders. Haematologica 1997;82:152-155.
26. 26. Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of Pentostatin versus interferon alpha-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol 1995;13:974-982.
27. 27. Kampmeier P, Spielberger R, Dickstein J, et al. Increased incidence of second neoplasms in patients treated with interferon alpha for hairy cell leukemia: a clinicopathologic assessment. Blood 1994;83:2931-2938.
28. 28. Pawson R, A'Hern R, Catowsky D. Second malignancy in hairy cell leukemia: no evidence of increased incidence after treatment with interferon alpha. Leuk Lymphoma 1996;22: 103-106.
29. 29. Tura S, Fiacchini M, Zinzani PL, et al. Splenectomy and the increasing risk of second leukemia in Hodgkin's disease. J Clin Oncol 1993;11:925-933.
30. 30. Linet MS, Nyren O, Gridley G, et al. Risk of cancer following splenectomy. Int J Cancer 1996;66:611-618.
31. 31. Barosi G, Ambrosetti A, Centra A, et al. Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Blood 1998;91:3630-3636.